top of page
Browse by category
Search
Journal Watch 6/11/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Omada survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals
Omada Health has released findings from an attitudinal survey of 1,000 non-Omada members to better understand the needs of consumers...
Cytoki Pharma doses first patient in Phase 2 study of CK-0045 for obesity and T2DM
Cytoki Pharma has announced the first patient has received CK-0045 in a Phase 2 proof-of-concept trial evaluating efficacy, safety and...
Endevica Bio spins off new company Abisati to develop weight loss drug
Endevica Bio is to spin-off of a newly created company called Abisati to develop an oral weight loss treatment that has shown efficacy in...
STEP 9: Semaglutide reduces knee osteoarthritis-related pain in people with obesity
Results from STEP 9 phase 3 clinical trial shows that studied semaglutide 2.4mg, compared to placebo as an adjunct to lifestyle...
Palatin completes study enrolment of bremelanotide plus tirzepatide to treat obesity
Palatin Technologies has completed enrolment in the study entitled "BMT-801, A Phase II, Randomized, Double-Blind, Placebo-Controlled,...
Browse by tag
bottom of page